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Exploring Life and Death at the Cellular Level: An 
Examination of How Our Cells Can Live Without Us 
by Emily Schmitt 
Introduction 
During the academic year (2012–2013) students and faculty in the Farquhar College of Arts and 
Sciences focused on the annual theme of “Life and Death.” To this end, we have been focusing 
all aspects of academic growth around this theme. It has guided our coursework, study groups, 
invited lecture series, Faculty Lecture Series, and even our Commencement speaker’s address 
(Farquhar College of Arts and Sciences, 2013). In this paper the idea of life and death will be 
examined from a cellular and molecular level, and the idea of what happens to our biological 
pieces (cells, proteins, tissues, etc.) once they are separated from our bodies will be explored. 
This idea has become increasingly more intriguing as humanity has discovered ways of keeping 
these biological parts viable and useful while outside of the original body from which they were 
derived (Lodish et al., 2012). When thinking about how to approach the annual theme from a 
biological point of view, I began asking students and community members, “Do you really think 
that a person’s cells can live outside the body?” Most had not given the idea much thought and 
were astonished to learn that the answer was a resounding, “Yes!” Although it is not that likely, 
even your own cells could be living in a culture dish somewhere right now without your 
knowledge! (Eiseman and Haga, 1999). This paper explores the history of cell culture, including 
cell strains and lines, their purpose in basic research and medical advances, and some of the legal 
and ethical underpinnings surrounding their development and use. 
Historical Overview of Cell Culture 
Starting in 1907, Ross Harrison, a scientist with dual degrees (M.D. and Ph.D.) and a faculty 
member at Johns Hopkins and then at Yale, grew nerve fibers from frogs outside the frog’s body 
in Petri dishes (Corning Life Sciences, 2013). A few years later, Alexis Carrel (an accomplished 
surgeon and cellular researcher who worked at the Rockefeller Institute of Medical Research for 
33 years) became very successful in tissue culture. He was able to maintain tissues outside the 
body in dog, cat, rat, guinea pig, and human tumor models for several months (PBS.org, 2013). 
In the 1930s, Charles Linbergh, of aviation fame, engineered devices to make cell culture easier. 
Although human cell lines became possible in the 1950s, other types of cells had been cultured 
previously for at least an additional 50 years. The concept of cells living outside of their host has 
been possible for at least 100 years. By the 1950s large scale bioreactors were in place to allow 
for the widespread production of cells for various research applications, including vaccine 
development. These bioreactors are involved in an annual multi-billion dollar industry in the 
U.S., with additional revenues throughout the world (Corning Life Sciences, 2013). Cell culture 
is an extremely valuable tool for the study of various aspects of biological science, including cell 
biology, virology, and cancer. It is also a major production tool for the development of cell-based 
vaccines, monoclonal antibodies, and cell-based drugs (Rivard, 2013). 
Cell Strains vs. Cell Lines 
There are two main categories of cell culture (growing cells outside the original organism): 
primary and transformed. Primary cell culture is also referred to as the development of cell 
strains. The cultivation of these cells are begun from normal animal tissues (often skin, kidney, 
liver, or others). The cells in these tissues are specifically treated to break cell to cell and cell to 
matrix adhesions. Then the cells are grown on nutrient-rich media in dishes. These cells will 
typically divide a finite number of times (about 50) and then stop growing. However, this 
process can still yield a large mass of cells in culture. For example, if one starts with 10 billion 
cells, 50 doublings can produce 1020 cells, a number which is roughly equivalent to the weight of 
1,000 people. The cell strain can be frozen before it goes into senescence, thus making it viable 
for a longer time (Lodish et al., 2012). On the other hand, transformed cell cultures have been 
found to be immortal. These cells can divide continually in culture for seemingly endless 
generations. This type of cell culture is typically derived from cancerous tissue and although they 
do undergo a period of senescence in culture, they emerge as a culture of cells with an indefinite 
life span (Lodish et al., 2012). There are entire catalogs available specifically dedicated to 
supplying researchers with the products involved in cell culture (American Type Culture 
Collection, 2013). These cells derive from a variety of sources and most of them are from human 
tumors. There are also some examples of normal fetal-derived human cells available for sale 
(Table 1; Figure 1). The ability of scientists to work with cells in culture has transformed our 
understanding of life at its most basic unit (Hayflick, 2012; Masters, 2002). For example, the 
number of scientific papers that have been published using the top 10 major cell lines alone has 
resulted in over 140,000 publications, with the vast majority (60,000) coming from the HeLa cell 
line (Biba, 2010). There are currently more than 4,000 cell lines available for sale from a variety 
of companies and organizations such as the American Type Culture Collection, the Coriell 
Institute for Medical Research (www.coriell.org), the European Collection of Cell Cultures 
(ECCC); (http://www.hpacultures.org.uk/), the German Collection of Microorganisms and Cell 
Cultures (DSMZ); (http://www.dsmz.de/), and the Bioresource and Collection Center (FIRDI-
Taiwan); (http://www.firdi.org.tw/EngWeb/2003/bcrc.htm). 
Table 1: Some of the most popularly available and used cell lines along with their biological 
source, cell type and reference price for a single vial to be shipped overnight to the 
researcher on dry ice. These cell lines were found in the American Type Culture Collection 
online catalog. Retrieved March, 2013 from www.atcp.org. 
Cell Line Biological Source Cell Type Reference price from 
www.atcc.org 
MCF7  69 year; human Caucasian 
female  
invasive breast carcinoma  $431  
JURKAT  14 year old boy  T cell leukemia; 
peripheral blood  
$431  
HEK-293  Human fetus  Epithelial  $431  
HT-29  44 year; human Caucasian 
female  
Epithelial; colon 
adenocarcinoma  
$431  
LNCaP  50 year; human Caucasian 
male  
Prostrate; carcinoma  $431  
HeLa  31 year; human 
Black female  
Cervix; adenocarconoma  $431  
WI-38  3 month; surgically aborted 
female Caucasian fetus  
Normal lung fibroblast  $431  
MO  50 year, Caucasian male  T lumphocyte; hairy cell 
leukemia  
$551  
  
  


 Figure 1: Low density and high density microscopic views of a few cell lines available from the 
American Type Culture Collection ( www.atcc.org ). 
The HeLa Cell Line 
Arguably, the most well-known of all the human cell lines is currently the HeLa line. In large 
part this increased awareness is due to the recently published book, The Immortal Life of 
Henrietta Lacks (Skloot, 2010). These cells were taken while the patient, Henrietta Lacks, a 31 
year old woman of low socioeconomic status and African American ancestry was being treated 
for a malignant tumor (carcinoma) of the uterine cervix at Johns Hopkins Hospital. These cells 
were found to be quite different from the normal cells from which they had originated (Grady, 
2010). In fact, they were very fast replicating cells and did not have the growth requirements of 
normal cells. Ironically, these cells killed Henrietta very quickly in the prime of her life, leaving 
her husband and five young children without their wife and mother, while the cells have 
continued to live without her ever since (62 years and counting). Although these cells were 
devastating to their host body, they have provided scientists with the cellular tool to develop 
11,000 patents, more than 60,000 scientific publications, at least two Nobel prizes, and the polio 
vaccine. They have also assisted in developing in vitro fertilization procedures and many other 
medical and scientific applications. The HeLa cells have even been in space (Mullin, 2011). 
More than 50 million tons of these cells exist in freezers around the world and have been sold for 
many billions of dollars. The number of HeLa cells that exist in research laboratories around the 
world is enough to make up the mass of approximately 1 billion people (Zielinski, 2010). Yet, 
when they were first examined by Margaret Gey and Minnie (a lab technician) in the laboratory 
of Dr. George Gey at Johns Hopkins in 1951, the scientists were simply excited that these cells 
were growing and that they would not stop growing, especially since up until that point it had 
been exceedingly difficult to keep human cells alive in culture. Dr. George Gey sent these cells 
to any researcher (free of charge) who wanted to conduct research using these cells (Masters, 
2002). Although these cells came from Henrietta Lacks, they are very different from her regular 
cells. The HeLa cell line is infected with the most virulent strain of the human papillomavirus 
(HPV) known to exist, and these cells ultimately killed Henrietta. Still, Henrietta Lacks’ 
descendents feel that when they see the HeLa cells, they are looking at their ancestor. This view 
is particularly poignant for Henrietta’s youngest daughter, Deborah who recounts that the first 
time she was able to see the HeLa cells in a lab, she felt like she was seeing a piece of her mother 
for the first time. Her mother died when she was only 2 years old, and just less than a year after 
the birth of her last child, Joseph (Skloot, 2010). Through the public awareness campaign 
assisted by Rebecca Skloot and many researchers that use the HeLa cells, the descendents of 
Henrietta Lacks have been able to see their great-grandmother’s cells and be inspired by the 
good that has become of them. The great-grandchildren of Henrietta Lacks visit Johns Hopkins 
to see HeLa cells (Video embedded link; Franzos, 2011). 
Although it has been known for a long time that HeLa cells were far from normal, the genome of 
HeLa cells was recently sequenced, shedding light on just how different these cells really are 
from normal ones (Landry et al., 2013). HeLa cells do not have the typical number of 23 human 
chromosome pairs, and there are many insertions of the human papillomavirus (HPV) that have 
shown up within the human chromosomes (EMBL, 2013; Scudellari, 2013; Landry et al., 2013). 
These changes have caused many researchers to question whether or not HeLa cells are really 
even human, and as such whether they are the best model (or even relevant anymore) for human 
research (Masters, 2002). As a result of the HeLa genome being sequenced, many regions of 
chromosomes were found to be re-arranged in the wrong order and there were extra or fewer 
copies of many genes. This chromosome shattering (the breaking and reassembling of genetic 
information on chromosomes) was documented and the process is estimated to exist in at least 2–
3% of all human cancers (Landry et al., 2013). 
Do we have a right to our cells or cell products? 
Increasingly often the question of whether or not we have any property rights to our cells once 
they are no longer in our bodies is a topic of heated debate and even forms the basis of court 
cases (Skloot, 2006). Each of the following situations resulted in a different outcome regarding 
the patient and their samples. However, in all cases it seems to be clear that once the sample has 
left the body it is very difficult to claim it as one’s own anymore. Laws generally protect the 
human subject, not their biological samples (Rivard, 2013). Many patient and tissues rights 
advocates such as Lori Andrews, J.D., who is the Director of the Institute for Science, Law, and 
Technology and a Professor of Law at the Illinois Institute of Technology champions that people 
should control their tissues to protect themselves from potential harm (Andrews and Nelkin, 
2001). She urges us to reflect on how we can decide who gets our money after we die, shouldn’t 
we be able to say who has a right to our biological samples as well (Andrews and Nelkin, 1998)? 
While there have been many cases involving property rights of one’s biological samples (Skloot, 
2006), consider the highlights of each of the following cases. 
Henrietta Lacks 
In 1951, Henrietta Lacks could barely afford her medical care and many of her descendants 
remain unable to afford medical insurance today (Skloot, 2010). This may seem ironic given that 
some genetically modified modifications of the HeLa cell line sell for up to $10,000 (Truong, et 
al., 2012a and 2012b). A portion of the proceeds from the sale of The Immortal Life of Henrietta 
Lacks go to the promotion of making health care accessible, and provides other forms of 
financial assistance specifically for people whose biological samples have assisted scientific 
discoveries but whose samples were used without their knowledge, consent, or compensation 
(Skloot, 2010; Henrietta Lacks Foundation, 2013). The Rebecca Skloot website also promotes 
discussions between various readers of the Henrietta Lacks story ranging from her family 
members, to scientists, book club members, and the public at large (RebeccaSkloot.com; 
http://rebeccaskloot.com/the-immortal-life/readers-talk/hela-forum/). The original researcher 
(Dr. George Gey) from Johns Hopkins University did not personally profit from the use of 
Henrietta Lacks’ cells as he freely shared them with interested researchers. However, the fact 
remains that these cells were taken and used without the precise knowledge or consent of 
Henrietta or her family members who remained disenfranchised from the science and medical 
establishments that promoted their use as major discovery tools (Skloot, 2010). 
John Moore 
The case of John Moore and the (Mo) cell line appears to be a bit more nefarious (McLellan, 
2001). In 1976, John Moore, who was an Alaskan pipeline surveyor developed hairy-cell 
leukemia. He became the patient of Dr. David Golde, also a researcher at University of 
California-Los Angeles (UCLA). As part of treatment, John Moore had his spleen removed and 
went to see Dr. Golde for follow up visits to take blood and other fluids as part of his ongoing 
medical care. Eventually, Dr. Golde started asking for additional and more frequent samples and 
started paying for John’s visits. The process also began involving intricate consent forms stating 
that John understood his biological samples and any products derived from them did not belong 
to him. When John Moore refused to sign these consent forms, he was denied further medical 
care from Dr. Golde. He subsequently learned through his attorney that Dr. Golde was filing a 
patent on proteins developed from John’s T cell lymphocytes which had some interesting 
disease-fighting properties that were keeping John’s leukemia from progressing as quickly as 
expected. His cells naturally contained a unique protein that stimulates growth of white blood 
cells which fight infection (Skloot, 2006). The cell line is referred to as (Mo) and is estimated to 
be worth at least $3 billion (McLellan, 2001). John Moore brought a lawsuit against Dr. Golde 
and UCLA in 1984. This resulted in a long court case. In 1990, the supreme court of California 
ruled against Moore. However, Moore did prevail on two counts; lack of informed consent and 
breach of fiduciary duty. John Moore died in 2001. Rebecca Skloot sums up the outcome of the 
Mo court case in this way, “Any ownership you might have had in your tissues vanishes when 
they are removed from your body, with or without your consent. When you leave tissues in a 
doctor’s office or a lab, you abandon them as waste. Anyone can take your garbage and sell it—
the same goes for your tissue.” (Skloot, 2006). We are coming to understand that the “stuff” you 
leave behind in the hospital or doctor’s office may not always get thrown out. It may be used in 
research (with or without your knowledge), or it may get stored indefinitely, or simply get 
thrown out. More than 307 million tissue samples from more than 178 million people are 
currently being stored in the United States, and this number is estimated to be increasing by more 
than 20 million samples each year (Eiseman and Haga, 1999). 
Ted Slavin 
Unlike in the John Moore case, Ted Slavin’s doctor advised him that his cells were interesting. 
Ted Slavin was a hemophiliac who had been exposed to hepatitis. It was found that he had 
antibodies to hepatitis in his blood, but was not sick with hepatitis. Ted contacted laboratories to 
see if they wanted to buy his blood for this interesting property. They did want to buy his blood. 
In fact, he sold his serum for $10 per mL and $10,000 per L. This was income that he was able to 
have for the rest of his life and allowed him to pay for his medical care. While being paid for his 
blood samples, Slavin looked for a researcher of his choice to help him find a cure for hepatitis. 
Ted Slavin gave his antibodies to Dr. Baruch Bloomberg (his favorite researcher), who was a 
Nobel prize winning hepatitis research-scientist; Ted Slavin was very hopeful for a cure. In fact, 
Dr. Bloomberg was able to develop the first hepatitis B vaccine (Blumberg, et al., 1985). Ted 
Slavin later developed a company, Essential Biologicals, which recruited and empowered others 
with unique and potentially lucrative biological anomalies to provide their biological 
components to researchers (NPR: FreshAir, 2011; Washington, 2011). Current legislation 
regarding patient rights in relation to their cells and tissues is mostly based on the Federal Policy 
for the Protection of Human Subjects (known as The Common Rule). It was passed in 1981 for 
the protection of the whole person, not for their excised body parts, and samples are generally 
considered exempt as long as they are anonymous and experts are not sure what a “good and 
complex consent process” to allow researchers to use biological samples would look like (Skloot, 
2006; Washington, 2011). 
Dr. William Catalona 
In this case, Dr. William Catalona, a reputable prostate cancer researcher (Urological Research 
Foundation, 2013) working for Washington University collected approximately 4,000 prostrate 
and 250,000 blood samples from at least 36,000 men. He used very detailed consent forms and 
the patients were happy giving samples to their beloved and trusted Dr. Catalona. However, 
when Dr. Catalona left Washington University his patients requested that the samples be 
transferred to Dr. Catalona. Washington University declined and took possession of the samples 
as the intellectual property of their employee (Mangan, 2008). These samples are likely to be 
worth more than $15 million. This situation ended up in court, going all the way to the U.S. 
Supreme Court and was heard in January of 2008. It was decided that Washington University has 
outright ownership of the samples from the prostate cancer patients (Washington University in 
St. Louis, 2013). The samples do not belong to Dr. Catalona, but to his employer at the time the 
research was done (Mangan, 2008). 
Havasupai Indians 
This may be one of the only cases where the patients were able to go into the research lab and 
actually remove their samples from the freezers there as part of a spiritual and religious 
ceremony. They were one of the very few groups that have been able to get their samples back 
after having their trust violated. In this situation genetic samples were gathered from Havasupai 
Indian tribe members for use in research on diabetes, which occurs in high incidence in their 
population. However, these samples, collected under a very broad consent form, were actually 
used to study a wide variety of genetic variations, including those underpinning mental illness 
and related to the geographical origins of the tribe. Both of these are not culturally acceptable 
uses of the DNA samples for the Havasupai people (Harmon, 2010). The case of the Havasupai 
people against the University of Arizona was ruled on in 2010 and resulted in the assigning of 
individual rights to a person’s DNA sample. The University of Arizona spent at least $1.7 
million fighting various lawsuits by tribal members. The university eventually settled on 
$700,000 to 41 tribal members and additional assistance in the forms of scholarships and health 
aid to the tribal members (Harmon, 2010). 
Discussion 
It is a very interesting situation that now through the use of technology our cells can live 
separately from us, essentially without us. While cells are generally understood to be the most 
basic units of life, are they really life on their own (particularly in the case of multicellular 
organisms, like humans)? Cells from thousands of people are currently living on without them 
and have been useful for many purposes from medical breakthroughs to an improved basic 
understanding of how living systems work. Generally, the donors of this biological material are 
unaware and uncompensated for their contribution, while in some cases they do have knowledge 
and are sometimes compensated (Truog et al., 2012a; 2012b; Kominwea and Becker, 2012). 
United States laws remain a bit unclear and somewhat contradictory in this area (Truog et al, 
2012a, 2012b; Hayflick, 2012). Biological parts are often seen as just another research tool such 
as a beaker, petri dish, or test tube. However, we would all be wise to remember the humanity 
represented by these cells and other biological parts and pieces such that we remain aware of the 
life involved. By raising our sensitivity to the nature of life and its component parts, perhaps we 
can learn to cherish all life, all organisms, and the environment that sustains all life on this planet 
(D’Alessio, pers. com.). 
As biotechnology becomes more advanced, we are coming to realize that all of our biological 
parts do not stay with us for our entire lives. We are constantly shedding proteins and DNA in 
the form of our hair, bodily fluids, trace material left in chewing gum, tissues, and even in our 
excretory waste. In the last decade several artists have begun to bring this situation into the 
public eye. For example, information artist Heather Dewey-Hagborg creates facial 3D portraits 
using DNA she extracts from material she finds throughout New York City in public places 
(Squires, 2013). She has taken the DNA from discarded chewing gum, cigarette butts and even 
hair in public restrooms and analyzed it for a variety of sequences. Then she puts the genetic-
marker results into a sophisticated computer program that assigns facial structure (for a person at 
age 25) to the outcome of those genetic markers. With that knowledge, she uses a 3D printer to 
create a facial portrait of the sample’s source at age 25 (Gambino, 2013; Additional Information 
Links). In a similar vein, artists Ionat Zurr and Oron Catts have developed the Tissue and Culture 
Art Project (http://tcaproject.org/) in which they use living human cells and tissues to create 
works of art that have been on display in various galleries (Andrews, 2007). They are perhaps 
most well known for their piece, “Semi-Living Worry Dolls” (2000), in which they grew and 
displayed human cells on doll-shaped polymer scaffolding inside culture tubes (Andrews, 2007; 
Additional Information Links). 
In the end, many questions remain. Questions exist such as, Do you have any rights to your 
biological parts? How much of you have you left behind for others to potentially examine in 
various ways? How would you know if someone ever did use your discarded biological parts, or 
parts that you unknowingly left behind? Do these ideas disturb you or really not bother you at 
all? Are your cells possibly living separately from you? We stand on a biological frontier; 
biological information that was once considered personal and was definitely inaccessible is now 
becoming increasingly accessible for careful study. These molecules, cells, and tissues are the 
results of millions of years of evolution and they are in our bodies, giving us our life, and 
possibly contributing to our eventual death, but do they even belong to us (Reader Survey Poll: 
https://www.surveymonkey.com/s/CELLS)? 
Links to Additional Information 
1. An editorial illustration for Lisa Marginalia’s review of Rebecca Skloot’s book, The 
Immortal life of Henrietta Lacks. By the artist, Chiarara Andriole. October 2011. 
http://www.chiaraandriole.com/The-Immortal-Life-of-Henrietta-Lacks 
2. Official book trailer with Rebecca Skloot, The immortal life of Henrietta Lacks. 
http://www.youtube.com/watch?v=1vow1ePzuqo  
3. Images of HeLa cells and an interview with Rebecca Skloot on NPR’s Fresh Air radio 
program. February 2, 2010 http://www.npr.org/2010/02/02/123232331/henrietta-lacks-a-
donors-immortal-legacy 
4. Documentary regarding the DNA from Havasupai Indians. Blood Journey April 2010, by 
Kassie Bracken and Amy Harmon 
http://www.nytimes.com/video/2010/04/21/us/1247467672743/blood-journey.html 
Links to Art Using Biological Components 
5. The Tissue Culture and Art Project. The Semi-Living Worry Dolls. By Oron Catts and 
Ionat Zurr, Australia .http://sciencegallery.com/visceral/semi-living-worry-dolls/ 
6. Studio 360: Kurt Andersen’s DNA Mask Revealed by Kurt Andersen and Heather 
Dewey-Hagborg. February 7, 20913. http://www.youtube.com/watch?v=u1jgkykLBVI 
7. Excerpt from Hands-On Ideas: Genetics with Artist Heather Dewey-Hagborg 
http://www.youtube.com/watch?v=j2SjNSlRbvM 
8. Lifelike Masks created from DNA. May 7, 2013 by GeoBeatsNews 
http://www.youtube.com/watch?v=dN_STkxr91g 
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